Sequester Will Hinder Drug, Device Reviews, FDA Head Says
The U.S. Food and Drug Administration's top official on Friday warned Congress that the automatic budget cuts known as sequestration could undermine inspections and snarl reviews of new drugs and medical...To view the full article, register now.
Already a subscriber? Click here to view full article